HomeAI · summaries
Storia in 5 fonti
On Peptides, FDA Staff Scientists At Odds With Advisory Panel
Though FDA would normally follow a panel’s advice to move ahead with compounded peptides, it’s unclear how it will act, because FDA staff are opposed to easing access.
Confronto fonti
5 prospettive sulla stessa storiaTimeline cronologica
- ·
washingtonexaminer.com
The FDA stacked a panel with peptide sellers. Guess what it just greenlit
Stacking an FDA advisory panel with peptide sellers to greenlight unproven substances is regulatory surrender, not public reform.
- ·
cnn.com
FDA advisers support easing restrictions on six peptides. Here’s what those drugs are and what happens next | CNN
Peptides have become one of the hottest trends in wellness, with promises like faster muscle recovery and healthier aging. And six of these compounds cleared a major hurdle last…
